Pruritus Therapeutic Global Market Report 2025

Description

Pruritus therapeutic refers to the treatment of pruritus, an uncomfortable sensation that prompts a person to scratch. Pruritus can be caused by various factors, including contact with allergens, dry skin, pregnancy, and reactions to medications.

The main types of pruritus therapeutic treatments include corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and others. Corticosteroids are a type of anti-inflammatory medication that closely resembles the hormone cortisol naturally produced by the adrenal glands. Pruritus can manifest in different diseases such as atopic dermatitis or eczema, allergic contact dermatitis, urticaria, cutaneous T-cell lymphoma, and others. Treatment methods include external use through application, oral administration, and injection. These therapies are commonly employed by hospitals, clinics, and other medical facilities.

The pruritus therapeutic market research report is one of a series of new reports from The Business Research Company that provides pruritus therapeutic market statistics, including pruritus therapeutic industry global market size, regional shares, competitors with a pruritus therapeutic market share, detailed pruritus therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the pruritus therapeutic industry. This pruritus therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pruritus therapeutic market size has grown strongly in recent years. It will grow from $14.29 billion in 2024 to $15.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing prevalence of pruritus, advancements in research and development, growing aging population, expansion of healthcare infrastructure, increasing awareness among patients, collaborations and partnerships.

The pruritus therapeutic market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to continued research and innovation, emerging markets growth, rising healthcare expenditure, personalized medicine trend, regulatory support for innovation. Major trends in the forecast period include telemedicine and digital health integration, technological advancements, telehealth and digital health solutions, global regulatory landscape, biologics and immunomodulators, patient-centric approaches.

The growth of pruritus therapeutics is significantly fueled by the increasing incidences of skin disorders. Dermatologic conditions, such as acne, eczema, skin cancer, psoriasis, and vitiligo, collectively referred to as skin disorders, are on the rise. Pruritus therapeutics play a crucial role in treating various skin diseases, as pruritus is a predominant symptom in most cases. For instance, melanoma, as reported by the American Academy of Dermatology Association in April 2022, is expected to result in 7,650 deaths in 2022. Moreover, the American Cancer Society projects 97,610 new melanoma cases to be diagnosed in the United States in 2023. This increase in skin disorders underscores the driving force behind the growth of the pruritus therapeutic market.

The rising prevalence of chronic kidney disease (CKD) is anticipated to drive growth in the pruritus therapeutic market in the coming years. CKD is a long-term condition characterized by a gradual decline in kidney function and is categorized into five severity levels. Pruritus, commonly referred to as itching, is a common symptom associated with CKD. While the exact causes of pruritus in CKD are not fully understood, various factors may contribute to it. For example, in June 2023, Kidney Research UK, a charitable organization focused on research and advocacy for kidney diseases, reported that approximately 7.19 million people in the UK were living with chronic kidney disease, accounting for over 10% of the population. This number is projected to rise to 7.61 million by 2033. Consequently, the increasing incidence of chronic kidney disease is fueling the growth of the pruritus therapeutic market.

Product innovation emerges as a prominent trend in the pruritus therapeutic market, with major companies focusing on the development of innovative medications and treatments for pruritus and related conditions. An example is Maruho Co., Ltd., a Japan-based pharmaceutical company, which introduced the anti-IL-31 receptor, a humanized monoclonal antibody named Mitchga Subcutaneous Injection. Launched in August 2022, it serves as a treatment for itching associated with atopic dermatitis, inhibiting IL-31 signaling and addressing pruritus and skin inflammation.

Major companies in the pruritus therapeutic market are adopting a strategic partnership approach to address moderate-to-severe atopic dermatitis. This collaborative strategy involves leveraging each other's strengths and resources for mutual benefits. Amgen Inc., a US-based biopharmaceutical company, partnered with Kyowa Kirin to investigate rocatinlimab, a potential anti-OX40 monoclonal antibody for moderate to severe atopic dermatitis. The Phase 3 trial, known as ROCKET, is a global initiative aimed at studying the safety and effectiveness of rocatinlimab. This strategic partnership underscores the collaborative efforts in advancing therapeutic solutions.

In March 2023, Ipsen, a France-based biopharmaceutical company, acquired Albireo Pharma, Inc., a US-based biopharmaceutical company. This strategic acquisition adds promising therapies for uncommon cholestatic liver disorders, novel pipeline prospects, and technical and financial strength to Ipsen's portfolio. Albireo Pharma, Inc. specializes in developing and commercializing novel bile acid modulators for the treatment of orphan pediatric liver diseases, gastrointestinal disorders, and pruritus-related conditions in drug development.

Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pruritus therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pruritus therapeutic market includes revenues earned by entities by treating pruritus conditions with medicines such as aloe vera, menthol and petroleum jelly. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pruritus Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pruritus therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pruritus therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pruritus therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressant; Calcineurin Inhibitors; Others Types
2) By Disease Type: Atopic Dermatitis Or Eczema; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types
3) By Application: External Use; Oral; Injection
4) By End Use: Hospitals; Clinics; Other Uses
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics; Injectable Local Anesthetics
4) By Counterirritants: Menthol-Based Products; Camphor-Based Products
5) By Immunosuppressants: Systemic Immunosuppressants; Topical Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus; Pimecrolimus
7) By Other Types: Antidepressants; Phototherapy Treatments; Herbal Remedies
Companies Mentioned: Astellas Pharma Inc.; Bristol-Myers Squibb Company; Cipla Inc.; Eli Lilly and Company; Galderma Laboratories LP
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23683

1. Executive Summary

2. Pruritus Therapeutic Market Characteristics

3. Pruritus Therapeutic Market Trends And Strategies

4. Pruritus Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pruritus Therapeutic Growth Analysis And Strategic Analysis Framework

5.1. Global Pruritus Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pruritus Therapeutic Market Growth Rate Analysis
5.4. Global Pruritus Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pruritus Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pruritus Therapeutic Total Addressable Market (TAM)

6. Pruritus Therapeutic Market Segmentation

6.1. Global Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Others Types
6.2. Global Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atopic Dermatitis Or Eczema
Allergic Contact Dermatitis
Urticaria
Cutaneous T-Cell
Other Disease Types
6.3. Global Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Use
Oral
Injection
6.4. Global Pruritus Therapeutic Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other Uses
6.5. Global Pruritus Therapeutic Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Corticosteroids
Systemic Corticosteroids
6.6. Global Pruritus Therapeutic Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Antihistamines
Second-Generation Antihistamines
6.7. Global Pruritus Therapeutic Market, Sub-Segmentation Of Local Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Local Anesthetics
Injectable Local Anesthetics
6.8. Global Pruritus Therapeutic Market, Sub-Segmentation Of Counterirritants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Local Anesthetics
Injectable Local Anesthetics
6.9. Global Pruritus Therapeutic Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Systemic Immunosuppressants
Topical Immunosuppressants
6.10. Global Pruritus Therapeutic Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tacrolimus
Pimecrolimus
6.11. Global Pruritus Therapeutic Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antidepressants
Phototherapy Treatments
Antidepressants

7. Pruritus Therapeutic Market Regional And Country Analysis

7.1. Global Pruritus Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pruritus Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pruritus Therapeutic Market

8.1. Asia-Pacific Pruritus Therapeutic Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pruritus Therapeutic Market

9.1. China Pruritus Therapeutic Market Overview
9.2. China Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pruritus Therapeutic Market

10.1. India Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pruritus Therapeutic Market

11.1. Japan Pruritus Therapeutic Market Overview
11.2. Japan Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pruritus Therapeutic Market

12.1. Australia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pruritus Therapeutic Market

13.1. Indonesia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pruritus Therapeutic Market

14.1. South Korea Pruritus Therapeutic Market Overview
14.2. South Korea Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pruritus Therapeutic Market

15.1. Western Europe Pruritus Therapeutic Market Overview
15.2. Western Europe Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pruritus Therapeutic Market

16.1. UK Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pruritus Therapeutic Market

17.1. Germany Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pruritus Therapeutic Market

18.1. France Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pruritus Therapeutic Market

19.1. Italy Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pruritus Therapeutic Market

20.1. Spain Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pruritus Therapeutic Market

21.1. Eastern Europe Pruritus Therapeutic Market Overview
21.2. Eastern Europe Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pruritus Therapeutic Market

22.1. Russia Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pruritus Therapeutic Market

23.1. North America Pruritus Therapeutic Market Overview
23.2. North America Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pruritus Therapeutic Market

24.1. USA Pruritus Therapeutic Market Overview
24.2. USA Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pruritus Therapeutic Market

25.1. Canada Pruritus Therapeutic Market Overview
25.2. Canada Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pruritus Therapeutic Market

26.1. South America Pruritus Therapeutic Market Overview
26.2. South America Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pruritus Therapeutic Market

27.1. Brazil Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pruritus Therapeutic Market

28.1. Middle East Pruritus Therapeutic Market Overview
28.2. Middle East Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pruritus Therapeutic Market

29.1. Africa Pruritus Therapeutic Market Overview
29.2. Africa Pruritus Therapeutic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pruritus Therapeutic Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pruritus Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pruritus Therapeutic Market Competitive Landscape And Company Profiles

30.1. Pruritus Therapeutic Market Competitive Landscape
30.2. Pruritus Therapeutic Market Company Profiles
- 30.2.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Galderma Laboratories LP Overview, Products and Services, Strategy and Financial Analysis

31. Pruritus Therapeutic Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. Merck & Co. Inc.
31.3. Novartis AG
31.4. Pfizer Inc.
31.5. Sanofi SA
31.6. Abbott Laboratories
31.7. Almirall SA
31.8. Eisai Co. Ltd.
31.9. Glenmark Pharmaceuticals Ltd.
31.10. Ipca Laboratories Ltd.
31.11. Lupin Chemicals Ltd.
31.12. Cara Therapeutics Inc.
31.13. EPI Health LLC
31.14. AbbVie Inc.
31.15. Albireo Pharma Inc.

32. Global Pruritus Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pruritus Therapeutic Market

34. Recent Developments In The Pruritus Therapeutic Market

35. Pruritus Therapeutic Market High Potential Countries, Segments and Strategies

35.1 Pruritus Therapeutic Market In 2029 - Countries Offering Most New Opportunities
35.2 Pruritus Therapeutic Market In 2029 - Segments Offering Most New Opportunities
35.3 Pruritus Therapeutic Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer